If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
455.00    -2.00 (-0.44%)
Bid:
455.00
Ask:
458.00
Spread: 3.00 (0.659%)
Market Cap: £224.65m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update 1st Quarter Funds under Management

9 Oct 2019 07:55

RNS Number : 2626P
City of London Investment Group PLC
09 October 2019
Β 

Β 

City of London Investment Group PLC

9 October 2019

ο»Ώ

9th October 2019

Β 

CITY OF LONDONΒ INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

Β 

Trading Update - 1st Quarter Funds under Management (FuM)

Β 

City of LondonΒ (LSE: CLIG), a leading specialist asset management group offering a range of institutional products investing in closed-end funds, announces that as at 30th September 2019, FuM wereΒ US$5.3 billionΒ (Β£4.3 billion). This compares withΒ US$5.4 billionΒ (Β£4.3 billion) at the Company's year-end on 30th June 2019. A breakdown by strategy follows:

Β 

Β 

FuM ($mn)

Β 

Β 

Β 

Strategy Index

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Sep-19

Jun-19

%

Β 

Net

Β 

Β 

Β 

%

Β 

(estimate)

inc/dec

Β 

Flows

Β 

Β 

Β 

inc/dec

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

EM

4,058

4,221

-3.9%

Β 

-12

Β 

MSCI EM

Β 

-4.2%

DEV

849

729

16.5%

Β 

142

Β 

MSCI ACWI xUS

Β 

-1.8%

Opportunistic Value

245

233

5.2%

Β 

10

Β 

ACWI/Barclays Global Agg

Β 

0.4%

Frontier

186

206

-9.7%

Β 

-

Β 

S&P Frontier 150

Β 

-5.6%

Β 

5,338

5,389

Β 

Β 

140

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β Β Β Β Β 

Funds under Management excludes seed investments

Β 

IM Performance

Β 

IM performance was ahead of the benchmark over the quarter. Specifically, in the Emerging Market strategy NAV performances were positive and discounts narrowed marginally. In the Developed strategy relative returns were impacted by weak NAV performance from European and UK securities. In the Frontier strategy performance was negative due to exposure to Argentina.

Β 

There were continued flows into the Developed and Opportunistic Value strategies totaling $152 million, while flows were negative in the Emerging strategy and neutral in the Frontier strategy.

Β 

Operations

Β 

The Group's income currently accrues at a weighted average rate of approximately 75 basis points of FuM, net of third party commissions. "Fixed" costs are c.Β Β£1.1 millionΒ per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an estimated EIP charge of 5%, is approximatelyΒ Β£1.6 millionΒ per month based upon current FuM and a US$/Β£ exchange rate ofΒ US$1.23Β toΒ Β£1Β as at 30th September 2019.

Β 

The Group estimates that the post-tax profit for the first three months of the year will be approximatelyΒ Β£2.4 millionΒ (2018:Β Β£2.2 million).

Β 

Dividends

Β 

The final dividend ofΒ 18 penceΒ per share, subject to approval at the AGM on 21st October 2019, will be paid on the 29th October 2019, bringing the total dividend for the financial year 2018-19 toΒ 40.5 pence, including the special dividend of 13.5 pence paid in MarchΒ (2017-18:Β 27 pence, special dividend : nil).

Β 

Board Change

Β 

City of London Investment Group is pleased to announce that Mr. Carlos M Yuste will be joining the Board as an Executive Director as of 1st January 2020. Carlos is the Head of Business Development. He served on the Board as the Business Development Director from CLIG's initial listing in 2006 through 2015.

Β 

There is no further information required to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.Β 

Β 

For further information, please visit http://www.citlon.co.uk/ or contact:

Β 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

Β 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTEAKENESFNFEF
Date   Source Headline
29th Jun 20264:20 pmRNSPDMR Shareholding
29th Jun 20262:31 pmRNSEBT Share Purchase
24th Jun 20265:20 pmRNSEBT Share Purchase
22nd Jun 20264:51 pmRNSEBT Share Purchase
15th Jun 20263:05 pmRNSEBT Share Purchase
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.